In The News
Judge approves $180M settlement in stolen wages class action
Judge slaps real estate ‘mogul’ Sasha Hopkins with $1.25M fine
Google faces potential class action over AdTech dominance
High Court cases could push Blue Sky class action trial to 2026
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Court approves landmark $75M detention centre class action settlement
Burger ad beef between McDonald’s, Hungry Jack’s done
Bubble tea chain Chatime fined for underpaying staff
Class action probe accuses union of forcing staff to join Labor Party
Travelex wins opposition to blockchain tech company’s trade marks
Please login to bookmarkClose

US pharmaceutical giant Merck Sharp & Dohme has taken a unit of Indian generic manufacturer Lupin to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
Related articles
Merck Sharp & Dohme slams Wyeth vaccine patent claims as ‘hearsay and speculation’
Allens 2019-02-06 2:44 pm By Miklos Bolza
Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine
Allens 2018-12-03 2:44 pm By Miklos Bolza
Merck Sharp & Dohme loses key battle in trade mark case ahead of trial
Angela McDonald 2019-07-15 2:44 pm By Miklos Bolza
Wyeth loses privilege claim over Allens docs in Merck’s vaccine patent case
Allens 2019-10-01 2:44 pm By Miklos Bolza
Merck Sharpe & Dohme sues Lupin over Januvia patent
Healthcare 2020-09-07 2:44 pm By Cat Fredenburgh
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au